Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients

Journal of Infection in Developing Countries

Volumn 6, Issue 4, 2012, Pages 352-357

  Badiee, Parisa ^a   Alborzi, Abdolvahab ^a   Karimi, Mahammad ^a   Pourabbas, Bahman ^a   Haddadi, Pedram ^b   Mardaneh, Jalal ^c   Moieni, Mahsa ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aspergillosis; D glucan; Galactomannan; Hematologic disorder; Nested PCR

Indexed keywords

1,3 BETA GLUCAN SYNTHASE; FUNGAL DNA; GALACTOMANNAN;

ADOLESCENT; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

EID: 84859980085     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2110     Document Type: Article

References (31)

1. Kim MJ, Lee KS, Kim J, Jung KJ, Lee HG, Kim TS (2001) Crescent sign in invasive pulmonary aspergillosis: frequency and related CT and clinical factors. J Comput Assist Tomogr 25: 305-310.
2. Horger M, Einsele H, Schumacher U, Wehrmann M, Hebart H, Lengerke C, Vonthein R, Claussen CD, Pfannenberg C (2005) Invasive pulmonary aspergillosis: frequency and meaning of the "hypodense sign" on unenhanced CT. Br J Radiol 78: 697-703.
3. Burgos A, Zaoutis TE, Dvorak CC, Hoffman JA, Knapp KM, Nania JJ, Prasad P, Steinbach WJ (2008) Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 121:1286-1294.
4. Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ (2006) Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 117: 711-716.
5. Meyer MH, Letscher-Bru V, Jaulhac B, Waller J, Candolfi E (2004) Comparison of Mycosis IC/F and plus Aerobic/F media for diagnosis of fungemia by the bactec 9240 system. J Clin Microbiol 42: 773-777.
6. McDonald LC, Weinstein MP, Fune J, Mirrett S, Reimer LG, Reller LB (2001) Controlled comparison of BacT/ALERT FAN aerobic medium and BATEC fungal blood culture medium for detection of fungemia. J Clin Microbiol 39:622-624.
7. Miyazaki T, Kohno S, Mitsutake K, Maesaki S, Tanaka K, Ishikawa N, Hara K 1995 Plasma (1→3)-ß-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 33: 3115-3118.
8. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, Motokura T, Hirai H, Ogawa S (2004) Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→ 3)-ß-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 42: 2733-2741.
9. Lass-Flörl C, Gunsilius E, Gastl G, Freund M, Dierich MP, Petzer A (2005) Clinical evaluation ofAspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients. Mycoses 48: 12-17.
10. Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Pourabbas B (2009) Molecular diagnosis of Aspergillus endocarditis after cardiac surgery. J Med Microbiol 58: 192-195.
11. Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M (1996) PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J Clin Microbiol 34: 2464-2468.
12. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE;. (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group [EORTC/MSG] Consensus Group. Clin Infect Dis 46: 1813-1821.
13. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Amé S, Lutz P, Dufour P, Bergerat JP, Candolfi E (2002) Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 20: 1898-1906.
14. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ (2004) Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 190: 641-649.
15. Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F, Hamidfar R, Ambroise-Thomas P, Grillot R (2003) Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 41: 2184-2186.
16. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F (2001) Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 91: 311-318.
17. Pfeiffer CD, Fine JP, Safdar N (2006) Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 42: 1417-1427.
18. Zandijk E, Mewis A, Magerman K, Cartuyvels R (2008) False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate. Clin Vaccine Immunol 15: 1132-1133.
19. Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, Rousselot P, Raffoux E, Menotti J, Derouin F, Ribaud P, Sulahian A (2006) Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 44: 389-394.
20. Wheat LJ and Walsh TJ (2008) Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay. Eur J Clin Microbiol Infect Dis 27: 245-251.
21. Badiee P, Alborzi A, Malekhosseini SA, Nikeghbalian S, Shakiba E (2010) Determining the incidence of aspergillosis after liver transplant. Transplant Experimental and Clinical Transplantation 3: 220-223.
22. Hummel M, Spiess B, Roder J, von Komorowski G, Dürken M, Kentouche K, Laws HJ, Mörz H, Hehlmann R, Buchheidt D (2009) Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. J Med Microbiol 58: 1291-1297.
23. Ahmad S, Khan ZU, Theyyathel AM (2007) Diagnostic value of DNA, (1→3)-ß-D-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus. Diagn Microbiol Infect Dis 59: 165-171.
24. Suarez F, Lortholary O, Buland S, Rubio MT, Ghez D, Mahé V, Quesne G, Poirée S, Buzyn A, Varet B, Berche P, Bougnoux ME (2008) Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. J Clin Microbiol 46: 3772-3777.
25. Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H (1997) False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 44: 1413-1418.
26. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR (2006) Reactivity of (1?3)-ß-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 50: 3450-3453.
27. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A (2001) Elevation of blood (1→3)-ß-D-glucan concentrations in hemodialysis patients. Nephron 89: 15-19.
28. Ikemura K, Tanaka H, Yoshioka T, Sugimoto T (1990) Interference in endotoxin and fungal polysaccharide assays from blood products and antimicrobial agents. Rinsho Byori 38: 87-92.
29. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL (2005) Evaluation of a (1-→3)-ß-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43: 5957-5962.
30. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10: 882-885.
31. Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, Matsuura S, Duvoisin B, Bille J, Calandra T, Marchetti O (2008) 1→3-ß-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 46:878-885.